You have searched for "Hospitalizations"
Showing 21-30 of 754
(Reuters) -A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.
(Reuters) -Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
BRASILIA (Reuters) - COVID-19 deaths and infections have declined across the Americas for the 8th consecutive week, the Pan American Health Organization (PAHO) said on Wednesday, warning that a very high percentage of hospitalized cases now are unvaccinated people.
(Reuters) - Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in an interview ahead of the Reuters Total Health conference, which will run virtually from Nov. 15-18.
The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.
Asian markets were mixed on Monday, with Hong Kong’s benchmark down more than 2% after troubled property developer China Evergrande’s shares were suspended from trading.
(Reuters) -Worldwide deaths related to COVID-19 surpassed 5 million on Friday, according to a Reuters tally, with unvaccinated people particularly exposed to the virulent Delta strain.
Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday
LOS ANGELES (Reuters) - The return of fans to NFL games this season has come as a welcome boost to a nation reeling from the COVID-19 pandemic, which has claimed thousands of lives and forced changes to almost every facet of American life.
The U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday recommended a booster shot of the Pfizer and BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with underlying medical conditions that put them at risk of severe disease.